Allianz Asset Management GmbH
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1535323
MUNICH, 2M
Position in ALNY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$15,769,925
-$3,267,568 QoQ
Shares Held
47,662
-0.4% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 35.43493768620704.ToString("F0")%
Shared 0.ToString("F0")%
None 64.56506231379295.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allianz Asset Management GmbH holds $654,142,197 across 68 Biotechnology names. ALNY ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
301,196 | $232,716,076 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
610,297 | $115,376,647 | |
| 3 | MRNA |
Moderna, Inc.
|
988,908 | $50,236,526 | |
| 4 | EXEL |
Exelixis, Inc.
|
954,551 | $40,940,690 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
400,020 | $22,597,128 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,441,683 | $20,846,736 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
47,662 | $15,769,925 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
706,664 | $15,730,340 |
All Filings in ALNY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,769,925 | 47,662 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $19,037,493 | 47,875 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $48,708,096 | 106,816 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $67,172,256 | 205,993 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $59,000,179 | 218,503 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $25,618,434 | 108,871 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $7,372,453 | 26,806 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,416,282 | 18,174 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,720,766 | 11,514 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,639,352 | 13,789 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $2,559,272 | 14,451 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,152,053 | 16,595 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,735,366 | 18,647 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $4,361,589 | 18,353 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,352,078 | 21,743 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $7,250,348 | 49,711 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,336,292 | 44,928 | Shares | Defined | 2022-05-13 | |
| 2021-09-30 | $10,489,150 | 55,554 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $5,865,222 | 34,599 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,288,836 | 37,459 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,900,919 | 30,014 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,602,270 | 31,609 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,718,674 | 38,611 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,770,351 | 43,825 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||